Daily exposure to chlordecone, an organochlorine pesticide, increases cardiac fibrosis and atrial fibrillation vulnerability.

Atrial fibrillation Atrial fibrosis Chlordecone Inflammation Pesticides

Journal

Journal of hazardous materials
ISSN: 1873-3336
Titre abrégé: J Hazard Mater
Pays: Netherlands
ID NLM: 9422688

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 03 04 2024
revised: 13 08 2024
accepted: 13 08 2024
medline: 23 8 2024
pubmed: 23 8 2024
entrez: 22 8 2024
Statut: aheadofprint

Résumé

Chlordecone (CLD) is a carcinogenic organochlorine pesticide. CLD was shown to disturb the activity of cardiac Na 1) Daily ingestion of CLD induces arrhythmogenic cardiac remodeling. 2) A phase of CLD withdrawal can reduce CLD-induced AF susceptibility. Adult male Wistar rats (250 g-275 g) ingested daily-doses of CLD (0 μg/L, 0.1 μg/L, or 1 μg/L) diluted in their quotidian water for 4 weeks. From day (D)29 to D56, all rats received CLD-free water. Vulnerability to AF and cardiac function were evaluated at D28 and D56 by electrophysiological study, echocardiography, and optical-mapping. Levels of genes and proteins related to inflammation, fibrosis, and senescence were quantified by qPCR and immunoassays. Twenty-eight days of CLD exposure were associated with significantly increased AF vulnerability compared to CLD-free rats. Contamination with 1 μg/L CLD significantly reduced atrial conduction velocity (ERP, APD). CLD-weaning normalized food consumption and weight intake. However, after the CLD-withdrawal period of 28 days, AF inducibility, atrial inflammation (IL6, IL1β), and atrial fibrosis (Masson's trichrome staining) remained significantly higher in rats exposed to 1 μg/L CLD compared to 0 μg/L. Prolonged CLD ingestion provokes atrial conduction slowing and increased risk of AF. Although CLD-weaning, some persistent damages occurred in the atrium like atrial fibrosis and atrial senescence signals, which are accompanied by atrial inflammation and arrhythmogenicity.

Identifiants

pubmed: 39173376
pii: S0304-3894(24)02112-5
doi: 10.1016/j.jhazmat.2024.135533
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135533

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Roddy Hiram reports financial support was provided by Montreal Heart Institute Foundation. Roddy Hiram reports was provided by Fondation canadienne pour l innovation. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alexia Fundere (A)

Faculty of Pharmacy, University of Montpellier, Montpellier, France; Université des Antilles, Guadeloupe, Pointe-à-Pitre, France; Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Andrew Rose (A)

Department of Pharmacology and Therapeutics, McGill University, Canada.

Feng Xiong (F)

Department of Pharmacology and Therapeutics, McGill University, Canada; Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Kalai Mangai Muthukumarasamy (KM)

Department of Pharmacology and Therapeutics, McGill University, Canada; Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Yasemin Altuntas (Y)

Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Harika Dasari (H)

Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Louis Villeneuve (L)

Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Martin G Sirois (MG)

Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Jean-François Tanguay (JF)

Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Jean-Claude Tardif (JC)

Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada.

Roddy Hiram (R)

Montreal Heart Institute, Faculty of Medicine, University of Montreal, Montreal, Canada. Electronic address: roddy.hiram@icm-mhi.org.

Classifications MeSH